bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline
28. Mai 2024 19:16 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises bluebird bio, Inc....
bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline
13. Mai 2024 19:41 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises bluebird bio, Inc. ("bluebird"...
bluebird bio, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline
09. Mai 2024 21:52 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises bluebird bio, Inc. ("bluebird"...
Stockholder Alert: Robbins LLP Reminds BLUE Investors of Upcoming May 28, 2024 Lead Plaintiff Deadline in the Bluebird Bio, Inc. Class Action
09. Mai 2024 15:15 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug
bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline.
01. Mai 2024 18:55 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises bluebird bio, Inc. ("bluebird"...
Robbins LLP Reminds Investors of Bluebird Bio, Inc. to Contact the Law Firm for Information About the Class Action Against BLUE
26. April 2024 16:45 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug
BLUE Lawsuit: Robbins LLP Reminds Investors of bluebird bio, Inc. of Pending Lead Plaintiff Deadline
17. April 2024 19:42 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug
bluebird bio, Inc. (BLUE) Class Action Notice: Robbins LLP Reminds Stockholders of Lead Plaintiff Deadline in Class Action Against bluebird bio, Inc.
09. April 2024 14:37 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against bluebird bio, Inc. (BLUE)
30. März 2024 01:44 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its Drug
BlueBird Bio, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
13. April 2021 14:47 ET
|
Portnoy Law
LOS ANGELES, April 13, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of BlueBird Bio, Inc. (NASDAQ: BLUE) investors that...